Maria Shipkova
Central Institute for Clinical Chemistry and Laboratory Medicine
Klinikum Stuttgart
Stuttgart
Germany
Name/email consistency: high
- Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay. Shipkova, M., Schütz, E., Besenthal, I., Fraunberger, P., Wieland, E. Ther. Drug. Monit (2010)
- Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Shipkova, M., Lorenz, K., Oellerich, M., Wieland, E., von Ahsen, N. Clin. Chem. (2006)
- Glucuronidation in therapeutic drug monitoring. Shipkova, M., Wieland, E. Clin. Chim. Acta (2005)
- Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Shipkova, M., Armstrong, V.W., Oellerich, M., Wieland, E. Expert. Opin. Drug. Metab. Toxicol (2005)
- Determination of thiopurine methyltransferase activity in isolated human erythrocytes does not reflect putative in vivo enzyme inhibition by sulfasalazine. Shipkova, M., Niedmann, P.D., Armstrong, V.W., Oellerich, M., Wieland, E. Clin. Chem. (2004)
- Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue. Shipkova, M., Beck, H., Voland, A., Armstrong, V.W., Gröne, H.J., Oellerich, M., Wieland, E. Proteomics (2004)
- cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy. Shipkova, M., Spielbauer, B., Voland, A., Gröne, H.J., Armstrong, V.W., Oellerich, M., Wieland, E. Transplantation (2004)
